Shearman & Sterling Advises on Secondary Offering and Repurchase of Quest Diagnostics’ Common Stock

Shearman & Sterling represented Quest Diagnostics Incorporated in connection with an underwritten public offering of 15,377,600 shares of Quest’s common stock held by GlaxoSmithKline plc., its largest stockholder. Concurrently with the public offering, Quest repurchased the 15,377,551 shares of its common stock from GlaxoSmithKline plc. Following this offering and the repurchase, GlaxoSmithKline plc no longer holds common stock of Quest. Deutsche Bank Securities Inc. and J.P. Morgan Securities LLC acted as joint bookrunners for the offering. Quest Diagnostics is the world’s leading provider of diagnostic testing, information and services.

More >>

Tags:  Shearman & Sterling LLP

Davis Polk – Savient Pharmaceuticals, Inc. $230 Million Convertible Senior Notes Offering

Davis Polk advised J.P. Morgan Securities LLC as the sole book-running manager and representative of the underwriters on a registered public offering by Savient Pharmaceuticals, Inc. of $230 million aggregate principal amount of its 4.75% convertible senior notes due 2018 (which included the full exercise of the over-allotment option). 

More >>

Tags:  Davis Polk & Wardwell LLP

Cooley Advises Epocrates, Inc. on its Initial Public Offering

Cooley LLP announced that it represented Epocrates, Inc. (NASDAQ: EPOC), in connection with its initial public offering of common stock.  Underwriters include J.P. Morgan Securities LLC and Piper Jaffray & Co., serving as joint book-running managers, and William Blair & Company, L.L.C. and JMP Securities LLC, acting as co-managers.

More >>

Tags:  Cooley LLP

Olswang Secures the Sale of Goviral to AOL Europe

Olswang announces that it has advised the selling shareholders on the sale of goviral to AOL Europe. Established in 2005, goviral is a video distribution network that delivers branded content over the internet for some of the world’s largest and most esteemed brands, media agencies creative agencies and content producers. The transaction was completed for $74.1 million in cash with an additional $22.6 million of consideration being paid over two years following completion.

More >>

Tags:  CMS

CMS Advises Largest Dental Corporate Group in UK

CMS Cameron McKenna LLP is pleased to have advised longstanding client Integrated Dental Holdings Limited (“IDH”) on its merger with with Associated Dental Practices (“ADP”) in a deal worth some £450 million. The Carlyle Group (“Carlyle”)  will hold a majority stake in the newly combined entity and Palamon will share joint governance.  The proposed merger of IDH and ADP is subject to the relevant regulatory approvals.

More >>

Tags:  CMS